JUL 05, 2020 12:33 PM PDT

Iron Build-up in Brain Linked to Alzheimer's

WRITTEN BY: Annie Lennon

Researchers from the Medical University of Graz in Austria have found a link between the build-up of iron in the brain's neocortex and cognitive decline in people with Alzheimer's disease.

Previous research has already established a link between unusually high levels of iron in the brain and Alzheimer's disease. In particular, iron deposits have been found to correlate with amyloid-beta accumulation, a protein that forms plaques between neurons in the brains of people with Alzheimer's and disrupts cell function. 

For the new study, the researchers developed a new MRI technique using a 3T MRI scanner, that allowed them to achieve an optimal trade-off between resolution and scan time, to best map iron deposits in different areas of the participants' brains. 

In particular, they used it to examine baseline levels of brain iron in 100 people with Alzheimer's disease and 100 healthy controls. Among those with Alzheimer's, 56 also underwent neuropsychological testing and brain MRI at an average follow-up time of 17 months. 

"We found indications of higher iron deposition in the deep gray matter and total neocortex, and regionally in temporal and occipital lobes, in Alzheimer's disease patients compared with age-matched healthy individuals," says Dr. Reinhold Schmidt, one of the study's co-authors. 

Iron accumulation also was linked to cognitive deterioration independently of loss in brain volume. Furthermore, iron concentration changes in the temporal lobes were found to correlate with cognitive decline in those with Alzheimer's. 

Schmidt thus concludes that these results are in line with previous suggestions that high iron concentrations encourage amyloid-beta deposits to form alongside general neurotoxicity associated with Alzheimer's. 

The researchers are hopeful that their findings will inform the use of drugs, known as chelators, to reduce iron levels in the brain and body. They also hope that their MRI-based screening method will be used as a future diagnostic tool for Alzheimer's and to monitor treatment response. 

 

Sources: Neuroscience NewsTechnology Networks 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 14, 2020
Neuroscience
Researchers Pinpoint Neurons Affected by Epilepsy
OCT 14, 2020
Researchers Pinpoint Neurons Affected by Epilepsy
Video: Explains in more detail the different receptors affected by epilepsy. Researchers at the University of Copenhagen ...
NOV 07, 2020
Cannabis Sciences
Does Cannabis Make Bipolar Disorder Better or Worse?
NOV 07, 2020
Does Cannabis Make Bipolar Disorder Better or Worse?
While anecdotal evidence and some case studies suggest cannabis may benefit those with bipolar disorder, studies have re ...
NOV 08, 2020
Cannabis Sciences
Can Cannabis Treat Epilepsy?
NOV 08, 2020
Can Cannabis Treat Epilepsy?
There has been growing interest in recent years for cannabis to treat central nervous system disorders. And so far, ther ...
NOV 15, 2020
Neuroscience
Brain Chemical Noradrenaline Helps Us Adapt to Uncertainty
NOV 15, 2020
Brain Chemical Noradrenaline Helps Us Adapt to Uncertainty
Researchers from the University of Cambridge and University College London have found that a neurochemical known as nora ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
DEC 29, 2020
Cannabis Sciences
What Happens When You Combine Cannabis with Psychedelics?
DEC 29, 2020
What Happens When You Combine Cannabis with Psychedelics?
Despite the growing popularity of cannabis and psychedelics, there is a shortage of research on how the two interact. Be ...
Loading Comments...